Breaking News: IDSA guidelines under scrutiny
Turns out it's not nice -- or particularly legal -- to stack the panel with people who stand to make loads of cash from drug and insurance companies, Lyme disease diagnostic tests and patents. Stay tuned for developments. It's bound to get wild in the coming weeks and months, especially with IDSA-loving Dr. Gary Wormser shrugging off the investigation and calling it "absurd." Conflicts? What conflicts?
This significant turn of events could soon impact your ability to get proper treatment. Meantime, we'll continue to interview physicians who specialize in Lyme and who can give us the inside scoop and help us understand the ramifications of the reassessment.
Please become a member to hear upcoming interviews with Lyme experts on this issue.
Read the IDSA's press release.